These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36154305)

  • 1. Life Experiences of Patients With Multiple Sclerosis About Their Spasticity: A Phenomenological Study.
    Özkan İ; Polat Dunya C; Demir S
    Clin Nurs Res; 2023 Jan; 32(1):49-59. PubMed ID: 36154305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The meaning of spasticity to people with multiple sclerosis: what can health professionals learn?
    Morley A; Tod A; Cramp M; Mawson S
    Disabil Rehabil; 2013 Jul; 35(15):1284-92. PubMed ID: 23373525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding spasticity from patients' perspectives over time.
    Bhimani RH; McAlpine CP; Henly SJ
    J Adv Nurs; 2012 Nov; 68(11):2504-14. PubMed ID: 22339651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88).
    Hobart JC; Riazi A; Thompson AJ; Styles IM; Ingram W; Vickery PJ; Warner M; Fox PJ; Zajicek JP
    Brain; 2006 Jan; 129(Pt 1):224-34. PubMed ID: 16280352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Spasticity and everyday life in multiple sclerosis].
    Donzé C; De Sèze J
    Rev Neurol (Paris); 2012 Apr; 168 Suppl 3():S51-6. PubMed ID: 22721365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MObility ImproVEment with spasticity in multiple sclerosis in Europe: the MOVE 1 EU study.
    Vermersch P
    Neurodegener Dis Manag; 2014; 4(6):407-15. PubMed ID: 25531685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the management of multiple sclerosis symptoms: pathophysiology and assessment of spasticity in multiple sclerosis.
    Tintoré M
    Neurodegener Dis Manag; 2015; 5(6 Suppl):15-7. PubMed ID: 26611266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity.
    Oreja-Guevara C
    Expert Rev Neurother; 2012 Apr; 12(4 Suppl):3-8. PubMed ID: 22509985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life: effect of reduced spasticity from intrathecal baclofen.
    Gianino JM; York MM; Paice JA; Shott S
    J Neurosci Nurs; 1998 Feb; 30(1):47-54. PubMed ID: 9604822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spasticity in multiple sclerosis: Associations with impairments and overall quality of life.
    Milinis K; Tennant A; Young CA;
    Mult Scler Relat Disord; 2016 Jan; 5():34-9. PubMed ID: 26856941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spasticity in multiple sclerosis].
    Pappalardo A; Patti F; Reggio A; Guglielmino A; Mangiameli S
    Clin Ter; 2004 Apr; 155(4):135-8. PubMed ID: 15354762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Sativex on spasticity-associated symptoms in patients with multiple sclerosis.
    Meuth SG; Vila C; Dechant KL
    Expert Rev Neurother; 2015; 15(8):909-18. PubMed ID: 26166264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of symptoms associated with spasticity in patients with multiple sclerosis].
    Fernández-Pablos MA; Costa-Frossard L; García-Hernández C; García-Montes I; Escutia-Roig M;
    Enferm Clin; 2016; 26(6):367-373. PubMed ID: 27492746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients' experiences of adapting to multiple sclerosis: a qualitative study.
    Ghafari S; Fallahi-Khoshknab M; Nourozi K; Mohammadi E
    Contemp Nurse; 2015; 50(1):36-49. PubMed ID: 26213256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spasticity in patients with multiple sclerosis--clinical characteristics, treatment and quality of life.
    Flachenecker P; Henze T; Zettl UK
    Acta Neurol Scand; 2014 Mar; 129(3):154-62. PubMed ID: 24256407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lived experience of relapsing multiple sclerosis: a phenomenological study.
    Miller CM
    J Neurosci Nurs; 1997 Oct; 29(5):294-304. PubMed ID: 9361999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lived experiences of people with inflammatory bowel diseases: A phenomenological hermeneutic study.
    Demirtas A
    Int J Nurs Pract; 2022 Jun; 28(3):e12946. PubMed ID: 33864417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On a pathway to resigned acceptance: Patients' experiences of living with symptom clusters in oral cancer.
    Mathew A; Tirkey AJ; Pavamani SP; Steffen A; Lockwood MB; Patil CL; Doorenbos AZ
    Eur J Oncol Nurs; 2023 Feb; 62():102263. PubMed ID: 36682140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spasticity experience domains in persons with spinal cord injury.
    Mahoney JS; Engebretson JC; Cook KF; Hart KA; Robinson-Whelen S; Sherwood AM
    Arch Phys Med Rehabil; 2007 Mar; 88(3):287-94. PubMed ID: 17321818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of pharmacological treatment on patients with multiple sclerosis.
    Buesa-Estelléz A; Cano-de-la-Cuerda R; Ortiz-Gutiérrez RM; Palacios-Ceña D
    Disabil Health J; 2019 Oct; 12(4):615-621. PubMed ID: 31133483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.